No answer available

A »The pharmaceutical sector in Cambridge, UK – a globally recognised hub for life sciences – benefits from a dense ecosystem of contract manufacturing organisations (CMOs) and contract development and manufacturing organisations (CDMOs) that offer specialised chemical blending services. While the city itself is more famous for early-stage R&D and biotech, a number of companies with facilities in and around Cambridge provide comprehensive blending capabilities tailored to the rigorous quality and regulatory demands of drug substance and drug product manufacturing. Among the most prominent is **Sterling Pharma Solutions**, which operates a cGMP-compliant facility in nearby Dudley (a short distance from Cambridge) offering custom chemical synthesis and blending of potent and high-containment compounds, with expertise in liquid and powder blending for oral solid dosage forms. Similarly, **Piramal Pharma Solutions** maintains a strong presence in the region through its integrated CDMO services; its Cambridge-adjacent site focuses on complex synthesis and formulation, including controlled blending of APIs with excipients under strictly monitored conditions. Another key player is **Peakdale Molecular** (now part of Sygnature Discovery), which provides custom synthesis and chemical blending for preclinical candidates, though its core is discovery rather than large-scale blending. For larger commercial volumes, **Thermo Fisher Scientific** (Patheon) has a dedicated oral solid dose facility in the Cambridge area that includes high-shear and low-shear blending services, along with roller compaction and granulation capabilities. **Catalent** also supports the region with its inhalation and extrusion technologies, offering blending for dry powder and liquid formulations. Additionally, **Charles River Laboratories** – though primarily known for safety testing – has expanded into early-phase formulation blending through its recent acquisitions and partnerships in the Cambridge cluster. For niche blending, **Piramal’s Mukund site** (often used by Cambridge-based biotechs) provides high-potency blending, while **Bush

A »Sure! In Cambridge, you might consider reaching out to companies like **Piramal Pharma Solutions**, which offers contract blending and formulation services, or **PCI Synthesis**, known for custom chemical blending for pharmaceuticals. **Fuji Chemical Industries** also provides blending and milling services suited for the pharma sector. Additionally, **Mitsubishi Chemical's** CDMO division and **Quotient Sciences** have capabilities in contract blending and formulation development. For smaller-scale or specialized needs, **Southern Chemical Corporation** and **Spectrum Chemical** sometimes offer custom blending for pharma applications. I’d recommend contacting these firms directly to discuss your specific requirements—they can advise on batch sizes, regulatory compliance, and turnaround times. It’s always a good idea to verify their current capacity and certifications for pharma-grade blending in the Cambridge area. Hope this helps you find the right partner!

A »In response to your query regarding contract chemical blending services for the pharmaceutical sector in Cambridge, it is important to note that the Cambridge region—particularly the Cambridge–Boston biotech cluster in Massachusetts, UK, and Cambridge, UK—hosts a dense concentration of contract development and manufacturing organizations (CDMOs) and specialized chemistry service providers. While the specific landscape evolves rapidly, several established companies with a significant presence in or near Cambridge offer contract chemical blending as part of their broader pharmaceutical services. In the US Cambridge, firms such as PCI Synthesis, which operates a dedicated cGMP facility for blending and compounding active pharmaceutical ingredients (APIs) with excipients, provide precise dose formulation and powder blending for clinical and commercial batches. Similarly, Metrics Contract Services, part of Mayne Pharma, offers oral solid dose manufacturing with advanced blending technologies, including high-shear and fluid-bed granulation, tailored to early-stage and scale-up requirements. In the UK Cambridge, notable players include Sterling Pharma Solutions, which has a facility in nearby Dudley (Northumberland) but serves the Cambridge region with chemical blending and high-potency drug handling, ensuring compliance with EU GMP standards. Another key provider is Almac Group, with its UK headquarters in Craigavon but a strong client base in Cambridge for its pharmaceutical development services, including blending for clinical trial materials and commercial launch quantities. Additionally, Piramal Pharma Solutions operates a site in nearby Grangemouth, Scotland, but maintains a robust service offering for Cambridge-based pharma companies, specializing in complex blending of controlled substances and cytotoxic compounds. For more localized options, the Cambridge Science Park in the UK hosts start-ups and spin-outs from the University of Cambridge that often rely on CDMOs like Concept Life Sciences, which provides integrated drug discovery and development with cGMP blending capabilities. When selecting a contractor, one must consider their regulatory track record, scalability from milligram to kilogram quantities, and expertise in handling specialized requirements such as sterile blending, nano-milling, or lyophilization. Furthermore, many of these providers offer analytical support for blend uniformity, dissolution testing, and stability studies, which are critical for regulatory submissions. It is advisable to engage directly with these firms to discuss specific blending technologies—such as V-blending, tumble blending, or twin-screw extrusion—that align with your product's physicochemical properties. Ultimately, the Cambridge ecosystem benefits from a network of CDMOs that combine academic collaboration with industrial-scale manufacturing, ensuring that contract chemical blending services meet the rigorous quality and compliance demands of the pharmaceutical sector. For the most current and tailored recommendations, consulting industry directories or attending local biotech events such as the BPI Conference or BioInnovation Institute symposia can provide further insights into emerging players and capacity availabilities.

No answer available

No answer available

No answer available